Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$165.92M-23.5%$216.89M-11.0%$243.57M-9.8%$269.91M-5.3%$285.05M-11.6%
$33.42M+31.0%$25.5M+13.1%$22.54M-19.2%$27.88M-2.1%$28.49M-26.0%
$40.46M-0.1%$40.5M-10.7%$45.33M-2.9%$46.67M-6.2%$49.77M-0.6%
$251.74M-15.0%$296.25M-9.1%$325.87M-9.4%$359.76M-4.4%$376.28M-12.3%
$146.93M-3.0%$151.48M-4.5%$158.62M-2.5%$162.73M-2.2%$166.43M+1.2%
$129.43M0.0%$129.43M0.0%$129.43M0.0%$129.43M-19.0%$159.88M0.0%
$144.89M-4.4%$151.54M-18.5%$185.88M-3.7%$193.07M-3.3%$199.58M+2.4%
$713.22M-7.4%$770.58M-9.3%$849.19M-5.3%$896.97M-6.5%$959.75M-4.8%
$8.54M+193%$2.91M-63.6%$8M-30.6%$11.53M+21.0%$9.53M-20.3%
$5.44M0.0%$5.44M0.0%$5.44M0.0%$5.44M0.0%$5.44M0.0%
$42.62M-5.1%$44.92M-27.1%$61.57M-11.6%$69.68M+10.3%$63.16M+10.9%
$235.57M-17.7%$286.33M-0.4%$287.38M-0.4%$288.44M-0.4%$289.5M-0.3%
$344.13M-13.5%$397.87M-4.7%$417.33M-2.7%$428.98M-0.1%$429.48M-0.4%
$6.39M-36.9%$10.12M-77.9%$45.8M-35.8%$71.36M-35.7%$110.95M-21.3%
$211.56M-0.4%$212.38M-13.5%$245.44M-7.7%$265.86M-11.6%$300.61M-7.6%
$713.22M-7.4%$770.58M-9.3%$849.19M-5.3%$896.97M-6.5%$959.75M-4.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Maravai LifeSciences Holdings, Inc.'s total assets?
Maravai LifeSciences Holdings, Inc. (MRVI) holds $713.2M in total assets, down 25.7% year over year.
How much debt does Maravai LifeSciences Holdings, Inc. have?
Maravai LifeSciences Holdings, Inc. carries $270.9M in total debt against $211.6M of shareholders' equity, a debt-to-equity ratio of 1.28.
How much cash does Maravai LifeSciences Holdings, Inc. have?
Maravai LifeSciences Holdings, Inc. holds $165.9M in cash and equivalents.
Can Maravai LifeSciences Holdings, Inc. cover its short-term obligations?
Its current ratio is 5.91 — current assets exceed current liabilities.
Where does Maravai LifeSciences Holdings, Inc.'s balance sheet data come from?
Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.